161 related articles for article (PubMed ID: 17048456)
1. The role of 18F-FDG PET/CT in the evaluation of solid splenic masses.
Metser U; Even-Sapir E
Semin Ultrasound CT MR; 2006 Oct; 27(5):420-5. PubMed ID: 17048456
[TBL] [Abstract][Full Text] [Related]
2. Solid splenic masses: evaluation with 18F-FDG PET/CT.
Metser U; Miller E; Kessler A; Lerman H; Lievshitz G; Oren R; Even-Sapir E
J Nucl Med; 2005 Jan; 46(1):52-9. PubMed ID: 15632034
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT Findings in a Splenic Lymphangioma.
Ji T; Kuang A
Clin Nucl Med; 2015 Jul; 40(7):e375-7. PubMed ID: 26018722
[TBL] [Abstract][Full Text] [Related]
4. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
Karunanithi S; Sharma P; Roy SG; Vettiyil B; Sharma A; Thulkar S; Bal C; Kumar R
Clin Nucl Med; 2014 Sep; 39(9):772-6. PubMed ID: 25036015
[TBL] [Abstract][Full Text] [Related]
5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
6. Negative
Van de Wiele C; Verstraete K; Bourgeois S; Maes A
Hell J Nucl Med; 2017; 20(2):182-183. PubMed ID: 28697199
[TBL] [Abstract][Full Text] [Related]
7. Imaging diagnosis--FDG-PET/CT of a canine splenic plasma cell tumor.
Lee AR; Lee MS; Jung IS; Kim DY; Nham SS; Chung HW; Eom K
Vet Radiol Ultrasound; 2010; 51(2):145-7. PubMed ID: 20402398
[TBL] [Abstract][Full Text] [Related]
8. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
9. CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma.
de Jong PA; van Ufford HM; Baarslag HJ; de Haas MJ; Wittebol SH; Quekel LG; de Klerk JM
AJR Am J Roentgenol; 2009 Mar; 192(3):745-53. PubMed ID: 19234273
[TBL] [Abstract][Full Text] [Related]
10. Splenic infarction mimicking a necrotizing metastasis of malignant melanoma on F-18 FDG PET/CT.
Ahmadzadehfar H; Brockmann H; Schmiedel A; Biersack HJ; Ezziddin S
Clin Nucl Med; 2008 Aug; 33(8):571-2. PubMed ID: 18645383
[No Abstract] [Full Text] [Related]
11. Primary splenic epithelioid hemangioendothelioma with diffuse metastases revealed by FDG PET/CT imaging: A case report.
Li X; Ma X; Hao J; Dong C; Wang Y
Medicine (Baltimore); 2021 Apr; 100(13):e25065. PubMed ID: 33787588
[TBL] [Abstract][Full Text] [Related]
12. Solitary splenic lymphoma detected with (18)F-FDG-PET/CT.
Tamam M; Mulazimoglu M; Yavuz H; Aydin T; Filiz F; Ozpacaci T
Hell J Nucl Med; 2011; 14(2):179-80. PubMed ID: 21761026
[No Abstract] [Full Text] [Related]
13. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
14. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory pseudotumour of the spleen: the findings on F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Ryu JS; Um JW; Min BW
ANZ J Surg; 2010 Sep; 80(9):650-2. PubMed ID: 20857613
[No Abstract] [Full Text] [Related]
16. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
17. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
18. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT in Hepatosplenic Gamma-Delta T-Cell Lymphoma.
Quak E; Salaun V; Le Naoures C; Fruchart C
Clin Nucl Med; 2015 Sep; 40(9):730-1. PubMed ID: 26053728
[TBL] [Abstract][Full Text] [Related]
20. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
Kara T; Kara PO; Gedik GK; Sari O
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
